Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIGNATURE - 6-gene signature as predictor of response to oral corticosteroids in severe asthma and ACOS
2017-000495-28Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of prednisolone in severe asthma, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS) and eosinophilic asthma (EA), sponsored by Bispebjerg and Frederiksberg Hospital. Started Mar 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
severe asthmaAsthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)eosinophilic asthma (EA)
Beyond the preview
Go deeper on 2017-000495-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000495-28.